Michael J. Fox Foundation finds promise in Israeli Parkinson's ...
The Michael J. Fox Foundation for Parkinson's Research believes that Israeli company NeuroDerm has the potential to offer hope to patients suffering from Parkinson's disease. So much potential, in fact, that the foundation is awarding them a $490,000 grant to aid in research on their transdermal skin patch, used to maintain steady levels of Levodopa (L-Dopa) in patients with Parkinson's disease.
L-Dopa is the most efficient drug for the treatment of Parkinson's disease through the skin, and NeuroDerm's sophisticated patch maintains constant blood levels of the drug.
· Read The Full Parkinson's Disease Article From Israel 21C -->
·
Read All Parkinson's Disease News Stories -->